Mendaera is a healthcare technology company based in Silicon Valley, California, developing a handheld interventional platform that combines robotics, artificial intelligence (AI), real-time imaging, and virtual connectivity to enhance precision and consistency in percutaneous procedures across various medical specialties. Their goal is to scale robotics and AI to hundreds of millions of mainstream medical procedures, improving care delivery and patient outcomes. In September 2024, Mendaera secured $73 million in Series B financing to advance the development and commercialization of their platform. The company has also formed strategic partnerships, including a commercial agreement with Butterfly Network to integrate Ultrasound-on-Chip™ technology into their robotic system. Mendaera’s leadership team comprises experts in robotics, AI, and imaging, with experience in building multi-billion dollar companies and creating category-defining platforms in technology and healthcare. Their mission is to digitize clinical judgment and technical expertise, making high-quality care available for every patient at every care facility. (February 2025)